News Features Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate Michael O'Riordan November 27, 2017
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
Presentation CDM 2017 From Andreas Gruentzig to PCSK9: How Angioplasty Transformed Cardiovascular Care Presenter: Spencer B. King October 06, 2017
News Conference News ESC 2017 CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS Todd Neale August 30, 2017
News Conference News ESC 2017 P2Y12 Inhibitor Pretreatment Questioned in STEMI Todd Neale August 29, 2017
News Conference News EuroPCR 2017 Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate Caitlin E. Cox May 22, 2017